WAYZENT — 1876506
Application number
1876506
Registration number
TMA1040690
Type(s)
Word
Category
Trademark
CIPO Status
REGISTERED
TM5 status
LIVE/REGISTRATION/Issued
and Active
The trademark application has been registered with the Office.
Filed
2018-01-09
Registered
2019-07-12
Registration Expiry Date
2029-07-12
Registered Owner
NOVARTIS AG
4002 BASEL
SWITZERLAND
Agent
SMART & BIGGAR LP
Scotia Plaza, 40 King Street West
40th Floor
Toronto
ONTARIO M5H3Y2
Documents
Index headings
- WAYZENT
Goods (Nice class & Statement)
- 5
- (1) Pharmaceutical preparations for the prevention and treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and treatment of disorders of the musculo-skeletal system, namely, connective tissue disease, bone diseases, spinal diseases, back pain, fractures, sprains, cartilage injuries; pharmaceutical preparations for the prevention and treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases; pharmaceutical preparations for use in dermatology, namely, dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in hematology, namely for the treatment of blood disorders; pharmaceutical preparations for use in tissue and organ transplantation; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for use in gastroenterology; pharmaceutical preparations for prevention and treatment of ocular disorders and diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, systemic and topical anti-fungals
Claims
- Proposed Use in CANADA
Action History
| Action | Action date | Due date | Comments |
|---|---|---|---|
| Filed | 2018-01-09 | ||
| Created | 2018-01-09 | ||
| Formalized | 2018-01-11 | ||
| Search Recorded | 2018-05-25 | ||
| Approval Notice Sent | 2018-05-25 | 2018-06-22 | |
| Approved | 2018-07-12 | APPROVED BY PROGRAM EX200M1 | |
| Advertised | 2018-08-01 | Vol.65 Issue 3327 | |
| Allowance Notice Sent | 2018-11-21 | 2021-01-09 | |
| Allowed | 2018-11-21 | ||
| Registered | 2019-07-12 | 2029-07-12 | |
| Agent Changed | 2024-08-16 | From/De: 9681 To/A: 2502 | |
| Agent Changed | 2026-04-21 | Transferred From: 2502 To: 59 |